{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T14:23:46Z","timestamp":1788272626177,"version":"build-2803163510"},"reference-count":257,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22177083"],"award-info":[{"award-number":["22177083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277102"],"award-info":[{"award-number":["22277102"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004536","name":"Southwest Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004536","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2682022ZTPY032"],"award-info":[{"award-number":["2682022ZTPY032"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.bcp.2022.115295","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T03:24:04Z","timestamp":1665545044000},"page":"115295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases"],"prefix":"10.1016","volume":"206","author":[{"given":"Lan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2022.115295_b0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40035-017-0096-2","article-title":"Disease modification and Neuroprotection in neurodegenerative disorders","volume":"6","author":"Cummings","year":"2017","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.bcp.2022.115295_b0010","doi-asserted-by":"crossref","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Ann. Rev. Neurosci."},{"issue":"7628","key":"10.1016\/j.bcp.2022.115295_b0015","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nature20411","article-title":"Ageing, neurodegeneration and brain rejuvenation","volume":"539","author":"Wyss-Coray","year":"2016","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.bcp.2022.115295_b0020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2217\/epi-2019-0347","article-title":"Possible roles of epigenetics in stem cell therapy for Parkinson's disease","volume":"12","author":"Thompson","year":"2020","journal-title":"Epigenomics"},{"key":"10.1016\/j.bcp.2022.115295_b0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13148-017-0365-z","article-title":"Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders","volume":"9","author":"Delgado-Morales","year":"2017","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.bcp.2022.115295_b0030","doi-asserted-by":"crossref","unstructured":"C.H. Waddington, The epigenotype. 1942, Int. J. Epidemiol. 41(1) (2012) 10\u201313.","DOI":"10.1093\/ije\/dyr184"},{"key":"10.1016\/j.bcp.2022.115295_b0035","first-page":"58","article-title":"Epigenetic mechanisms in neurological and neurodegenerative diseases","volume":"9","author":"Landgrave-G\u00f3mez","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0040","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrn3818","article-title":"Epigenetic and transgenerational reprogramming of brain development","volume":"16","author":"Bale","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"38","key":"10.1016\/j.bcp.2022.115295_b0045","doi-asserted-by":"crossref","first-page":"23252","DOI":"10.1073\/pnas.1820837116","article-title":"The role of the genome in experience-dependent plasticity: Extending the analogy of the genomic action potential","volume":"117","author":"Clayton","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2022.115295_b0050","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.2002.tb04911.x","article-title":"The relations between genetics and epigenetics: a historical point of view","volume":"981","author":"Morange","year":"2002","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"7","key":"10.1016\/j.bcp.2022.115295_b0055","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10815-017-0931-5","article-title":"Genetics and epigenetics of varicocele pathophysiology: an overview","volume":"34","author":"Santana","year":"2017","journal-title":"J. Assist. Reprod. Genet."},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0060","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0065","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn.2017.46","article-title":"The emerging field of epigenetics in neurodegeneration and neuroprotection","volume":"18","author":"Hwang","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2017.08.005","article-title":"Progressing neurobiological strategies against proteostasis failure: Challenges in neurodegeneration","volume":"159","author":"Amanullah","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"24","key":"10.1016\/j.bcp.2022.115295_b0075","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting Huntingtin Expression in Patients with Huntington's Disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0080","first-page":"36","article-title":"Potent and sustained huntingtin lowering via AAV5 encoding miRNA preserves striatal volume and cognitive function in a humanized mouse model of Huntington disease","volume":"48","author":"Caron","year":"2020","journal-title":"Nucl. Acids Res."},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b0085","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.bcp.2006.06.016","article-title":"Chromatin structure and epigenetics","volume":"72","author":"Quina","year":"2006","journal-title":"Biochem. Pharmacol."},{"issue":"Pt 19","key":"10.1016\/j.bcp.2022.115295_b0090","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1242\/jcs.01390","article-title":"Epigenetic aspects of differentiation","volume":"117","author":"Arney","year":"2004","journal-title":"J. Cell Sci."},{"issue":"4173","key":"10.1016\/j.bcp.2022.115295_b0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.187.4173.226","article-title":"DNA modification mechanisms and gene activity during development","volume":"187","author":"Holliday","year":"1975","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.freeradbiomed.2012.05.024","article-title":"Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease","volume":"53","author":"Siddiqui","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2022.115295_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.834362","article-title":"Genetics and Epigenetics of Parathyroid Carcinoma","volume":"13","author":"Marini","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"7","key":"10.1016\/j.bcp.2022.115295_b0110","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tibs.2014.05.002","article-title":"New concepts in DNA methylation","volume":"39","author":"Jeltsch","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0115","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrg.2017.80","article-title":"The DNA methyltransferase family: a versatile toolkit for epigenetic regulation","volume":"19","author":"Lyko","year":"2018","journal-title":"Nat. Rev. Genet."},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b0120","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nsmb.2357","article-title":"RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesis","volume":"19","author":"Tuorto","year":"2012","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"5759","key":"10.1016\/j.bcp.2022.115295_b0125","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1126\/science.1120976","article-title":"Methylation of tRNAAsp by the DNA methyltransferase homolog Dnmt2","volume":"311","author":"Goll","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bcp.2022.115295_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2016.05.013","article-title":"Active DNA demethylation by DNA repair: Facts and uncertainties","volume":"44","author":"Schuermann","year":"2016","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.bcp.2022.115295_b0135","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.gde.2017.07.011","article-title":"TET proteins in natural and induced differentiation","volume":"46","author":"Scott-Browne","year":"2017","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41576-020-00287-8","article-title":"Active turnover of DNA methylation during cell fate decisions","volume":"22","author":"Parry","year":"2021","journal-title":"Nat. Rev. Genet."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2022.115295_b0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mrfmmm.2008.10.011","article-title":"Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases","volume":"667","author":"Migliore","year":"2009","journal-title":"Mutat. Res."},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/s18092823","article-title":"The Applications of Promoter-gene-Engineered Biosensors","volume":"18","author":"Feng","year":"2018","journal-title":"Sensors (Basel)"},{"issue":"5","key":"10.1016\/j.bcp.2022.115295_b0155","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/nar\/30.5.1139","article-title":"Methylation-dependent silencing at the H19 imprinting control region by MeCP2","volume":"30","author":"Drewell","year":"2002","journal-title":"Nucl. Acids Res."},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0160","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1074\/jbc.M210256200","article-title":"The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation","volume":"278","author":"Fuks","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0165","doi-asserted-by":"crossref","DOI":"10.1093\/dnares\/dsaa020","article-title":"Existence and possible roles of independent non-CpG methylation in the mammalian brain","volume":"27","author":"Lee","year":"2020","journal-title":"DNA Res."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/biom11020143","article-title":"The Role of H3K4 Trimethylation in CpG Islands Hypermethylation in Cancer","volume":"11","author":"Zardo","year":"2021","journal-title":"Biomolecules"},{"issue":"22","key":"10.1016\/j.bcp.2022.115295_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225649","article-title":"Role of MicroRNAs in Parkinson's Disease","volume":"20","author":"Goh","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0180","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-2836(84)90382-6","article-title":"Crystal structure of the nucleosome core particle at 16 A resolution","volume":"176","author":"Bentley","year":"1984","journal-title":"J. Mol. Biol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b0185","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.15252\/embr.201540945","article-title":"The interplay of histone modifications - writers that read","volume":"16","author":"Zhang","year":"2015","journal-title":"EMBO Rep."},{"issue":"6765","key":"10.1016\/j.bcp.2022.115295_b0190","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0195","doi-asserted-by":"crossref","first-page":"139","DOI":"10.15252\/embr.201541809","article-title":"Histones and histone modifications in perinuclear chromatin anchoring: from yeast to man","volume":"17","author":"Harr","year":"2016","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bcp.2022.115295_b0200","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fnins.2018.00649","article-title":"The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer's Disease","volume":"12","author":"Wood","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0205","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1021\/bi00889a003","article-title":"THE occurrence of epsilon-n-methyl lysine in histones","volume":"3","author":"Murray","year":"1964","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-016-0279-9","article-title":"Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives","volume":"9","author":"Song","year":"2016","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2019.05.007","article-title":"PRMTs and Arginine Methylation: Cancer's Best-Kept Secret?","volume":"25","author":"Jarrold","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bcp.2022.115295_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2018.08.021","article-title":"Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy","volume":"837","author":"Biswas","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0225","doi-asserted-by":"crossref","first-page":"e324","DOI":"10.1038\/emm.2017.11","article-title":"Writing, erasing and reading histone lysine methylations","volume":"49","author":"Hyun","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0230","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v14.i1.90","article-title":"Gastric cancer: An epigenetic view","volume":"14","author":"Tang","year":"2022","journal-title":"World J. Gastrointest. Oncol."},{"key":"10.1016\/j.bcp.2022.115295_b0235","article-title":"Overview of Histone Modification","volume":"1283","author":"Zhang","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"D1","key":"10.1016\/j.bcp.2022.115295_b0240","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv1002","article-title":"dbSUPER: a database of super-enhancers in mouse and human genome","volume":"44","author":"Khan","year":"2016","journal-title":"Nucl. Acids Res."},{"issue":"21","key":"10.1016\/j.bcp.2022.115295_b0245","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1002\/anie.200461346","article-title":"Epigenetics\u2013an epicenter of gene regulation: histones and histone-modifying enzymes","volume":"44","author":"Biel","year":"2005","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bcp.2022.115295_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114224","article-title":"Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective","volume":"182","author":"Gao","year":"2020","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b0255","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nsmb.2470","article-title":"Regulation of nucleosome dynamics by histone modifications","volume":"20","author":"Zentner","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bcp.2022.115295_b0260","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fnins.2015.00483","article-title":"Post-Translational Modifications of Histones in Vertebrate Neurogenesis","volume":"9","author":"Mitrousis","year":"2015","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0265","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"37","key":"10.1016\/j.bcp.2022.115295_b0270","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/sj.onc.1210618","article-title":"Structure and acetyl-lysine recognition of the bromodomain","volume":"26","author":"Mujtaba","year":"2007","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0275","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrm.2016.143","article-title":"Functions of bromodomain-containing proteins and their roles in homeostasis and cancer","volume":"18","author":"Fujisawa","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0280","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2016742118","article-title":"Histone H3Q5 serotonylation stabilizes H3K4 methylation and potentiates its readout","volume":"118","author":"Zhao","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6487","key":"10.1016\/j.bcp.2022.115295_b0285","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1126\/science.aaw8806","article-title":"Dopaminylation of histone H3 in ventral tegmental area regulates cocaine seeking","volume":"368","author":"Lepack","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b0290","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.bcp.2022.115295_b0295","article-title":"Role of Chromatin Architecture in Plant Stress Responses: An Update","volume":"11","author":"Bhadouriya","year":"2020","journal-title":"Front. Plant Sci."},{"issue":"15\u201316","key":"10.1016\/j.bcp.2022.115295_b0300","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1101\/gad.326066.119","article-title":"Dangerous liaisons: interplay between SWI\/SNF, NuRD, and Polycomb in chromatin regulation and cancer","volume":"33","author":"Bracken","year":"2019","journal-title":"Genes Dev."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0305","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrm.2016.148","article-title":"Histone variants on the move: substrates for chromatin dynamics","volume":"18","author":"Talbert","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b0310","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2016.117","article-title":"Non-coding RNAs as drug targets","volume":"16","author":"Matsui","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0315","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"20","key":"10.1016\/j.bcp.2022.115295_b0320","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1038\/emboj.2011.327","article-title":"microRNA-34c is a novel target to treat dementias","volume":"30","author":"Zovoilis","year":"2011","journal-title":"EMBO J."},{"issue":"18","key":"10.1016\/j.bcp.2022.115295_b0325","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1182\/blood-2017-06-788695","article-title":"Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis","volume":"130","author":"Alvarez-Dominguez","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0330","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13059-017-1348-2","article-title":"The multidimensional mechanisms of long noncoding RNA function","volume":"18","author":"Marchese","year":"2017","journal-title":"Genome Biol."},{"issue":"588","key":"10.1016\/j.bcp.2022.115295_b0335","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaw9277","article-title":"Long noncoding RNA NEAT1 mediates neuronal histone methylation and age-related memory impairment","volume":"12","author":"Butler","year":"2019","journal-title":"Sci. Signal"},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0340","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.pnpbp.2010.08.008","article-title":"Epigenetics in neurodegeneration: a new layer of complexity","volume":"35","author":"Marques","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25112496","article-title":"Resolving DNA Damage: Epigenetic Regulation of DNA Repair","volume":"25","author":"Karakaidos","year":"2020","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0350","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00439-013-1271-x","article-title":"Genetic syndromes caused by mutations in epigenetic genes","volume":"132","author":"Berdasco","year":"2013","journal-title":"Hum. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0355","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13072-017-0144-2","article-title":"Regions of common inter-individual DNA methylation differences in human monocytes: genetic basis and potential function","volume":"10","author":"Schr\u00f6der","year":"2017","journal-title":"Epigenetics Chromatin"},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0360","doi-asserted-by":"crossref","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","article-title":"Memory loss in Alzheimer's disease","volume":"15","author":"Jahn","year":"2013","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.bcp.2022.115295_b0365","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fgene.2018.00579","article-title":"The Epigenetics of Alzheimer's Disease: Factors and Therapeutic Implications","volume":"9","author":"Liu","year":"2018","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0370","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.arr.2013.05.003","article-title":"Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy","volume":"12","author":"Wang","year":"2013","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.bcp.2022.115295_b0375","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084259","article-title":"Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer's Disease","volume":"23","author":"Ilina","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0380","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.mcn.2004.09.007","article-title":"S-adenosylmethionine\/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production","volume":"28","author":"Fuso","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111363","article-title":"Neprilysin expression and functions in development, ageing and disease","volume":"192","author":"Nalivaeva","year":"2020","journal-title":"Mech. Ageing Dev."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0390","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.cell.2012.02.016","article-title":"Proline isomer-specific antibodies reveal the early pathogenic tau conformation in Alzheimer's disease","volume":"149","author":"Nakamura","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0395","first-page":"309","article-title":"The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes","volume":"78","author":"Lovestone","year":"1997","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.bcp.2022.115295_b0400","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1007\/s12035-015-9415-8","article-title":"The Role of MAPT in Neurodegenerative Diseases: Genetics","volume":"53","author":"Zhang","year":"2016","journal-title":"Mech. Therapy, Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0405","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41593-018-0291-1","article-title":"Epigenome-wide study uncovers large-scale changes in histone acetylation driven by tau pathology in aging and Alzheimer's human brains","volume":"22","author":"Klein","year":"2019","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b0410","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/nn.3786","article-title":"Alzheimer's disease: early alterations in brain DNA methylation at ANK1, BIN1, RHBDF2 and other loci","volume":"17","author":"De Jager","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b0415","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nn.3792","article-title":"The epigenetic landscape of Alzheimer's disease","volume":"17","author":"Lord","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0420","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/143269","article-title":"Targeting HDACs: a promising therapy for Alzheimer's disease","volume":"2011","author":"Xu","year":"2011","journal-title":"Oxid. Med. Cell Longev"},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0425","doi-asserted-by":"crossref","DOI":"10.1038\/nrn3427","article-title":"Histone acetylation: molecular mnemonics on the chromatin","volume":"14","author":"Gr\u00e4ff","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0430","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fncel.2015.00226","article-title":"Histone Acetylation Modifiers in the Pathogenesis of Alzheimer's Disease","volume":"9","author":"Lu","year":"2015","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0435","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fnagi.2019.00149","article-title":"Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer's Disease","volume":"11","author":"Cuadrado-Tejedor","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0440","doi-asserted-by":"crossref","first-page":"15423","DOI":"10.1038\/s41598-021-94923-w","article-title":"A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice","volume":"11","author":"Onishi","year":"2021","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2022.115295_b0445","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41588-020-0696-0","article-title":"An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer's disease","volume":"52","author":"Nativio","year":"2020","journal-title":"Nat. Genet."},{"issue":"Pt 3","key":"10.1016\/j.bcp.2022.115295_b0450","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/brain\/aws013","article-title":"Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies","volume":"135","author":"Irwin","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.bcp.2022.115295_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2014.01.038","article-title":"Targeting histone-modifications in Alzheimer's disease. What is the evidence that this is a promising therapeutic avenue?","volume":"80","author":"Fischer","year":"2014","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0460","doi-asserted-by":"crossref","first-page":"8384","DOI":"10.1038\/s41598-020-64452-z","article-title":"A meta-analysis of gene expression data highlights synaptic dysfunction in the hippocampus of brains with Alzheimer's disease","volume":"10","author":"Hosseinian","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2022.115295_b0465","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.3892\/mmr.2014.2013","article-title":"microRNA-9 attenuates amyloid\u03b2-induced synaptotoxicity by targeting calcium\/calmodulin-dependent protein kinase kinase 2","volume":"9","author":"Chang","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2013.02.003","article-title":"The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of A\u03b2 oligomers through Tau phosphorylation","volume":"78","author":"Mairet-Coello","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.bcp.2022.115295_b0475","first-page":"323","article-title":"Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways","volume":"3","author":"Holohan","year":"2012","journal-title":"Front. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0480","doi-asserted-by":"crossref","DOI":"10.3390\/genes9040174","article-title":"The Role of microRNAs in Alzheimer's Disease and Their Therapeutic Potentials","volume":"9","author":"Miya Shaik","year":"2018","journal-title":"Genes (Basel)"},{"issue":"5","key":"10.1016\/j.bcp.2022.115295_b0485","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0490","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.brainres.2011.04.035","article-title":"miR-29c regulates BACE1 protein expression","volume":"1395","author":"Zong","year":"2011","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0495","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nn.4188","article-title":"Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway","volume":"19","author":"Das","year":"2016","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0500","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/ene.13413","article-title":"Huntington's disease: a clinical review","volume":"25","author":"McColgan","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"18","key":"10.1016\/j.bcp.2022.115295_b0505","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","article-title":"Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro","volume":"24","author":"Trushina","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0510","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s13311-019-00782-9","article-title":"Cell-Autonomous and Non-cell-Autonomous Pathogenic Mechanisms in Huntington's Disease: Insights from In Vitro and In Vivo Models","volume":"16","author":"Creus-Muncunill","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"33","key":"10.1016\/j.bcp.2022.115295_b0515","doi-asserted-by":"crossref","first-page":"16593","DOI":"10.1073\/pnas.1904101116","article-title":"Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23","volume":"116","author":"Yablonska","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0520","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1073\/pnas.1221292110","article-title":"Extensive changes in DNA methylation are associated with expression of mutant huntingtin","volume":"110","author":"Ng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2022.115295_b0525","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fnmol.2019.00335","article-title":"Evaluation of Biochemical and Epigenetic Measures of Peripheral Brain-Derived Neurotrophic Factor (BDNF) as a Biomarker in Huntington's Disease Patients","volume":"12","author":"Gutierrez","year":"2019","journal-title":"Front. Mol. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0530","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1038\/s41467-020-18255-5","article-title":"DNA methylation study of Huntington's disease and motor progression in patients and in animal models","volume":"11","author":"Lu","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2022.115295_b0535","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.18632\/aging.101005","article-title":"Huntington's disease accelerates epigenetic aging of human brain and disrupts DNA methylation levels","volume":"8","author":"Horvath","year":"2016","journal-title":"Aging (Albany NY)"},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0540","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12017-013-8219-0","article-title":"Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington's disease","volume":"15","author":"Villar-Men\u00e9ndez","year":"2013","journal-title":"Neuromol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0545","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ab.2013.01.035","article-title":"A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease","volume":"436","author":"Thomas","year":"2013","journal-title":"Anal. Biochem."},{"issue":"32","key":"10.1016\/j.bcp.2022.115295_b0550","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1311323110","article-title":"Targeting H3K4 trimethylation in Huntington disease","volume":"110","author":"Vashishtha","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"50","key":"10.1016\/j.bcp.2022.115295_b0555","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","article-title":"ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease","volume":"103","author":"Ryu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0560","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuron.2004.06.002","article-title":"CBP histone acetyltransferase activity is a critical component of memory consolidation","volume":"42","author":"Korzus","year":"2004","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b0565","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nbd.2006.04.011","article-title":"Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin","volume":"23","author":"Jiang","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.1016\/j.bcp.2022.115295_b0570","doi-asserted-by":"crossref","first-page":"e41423","DOI":"10.1371\/journal.pone.0041423","article-title":"Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease","volume":"7","author":"McFarland","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2019.02.003","article-title":"Cell-Type-Specific Gene Expression Profiling in Adult Mouse Brain Reveals Normal and Disease-State Signatures","volume":"26","author":"Merienne","year":"2019","journal-title":"Cell Rep."},{"issue":"49","key":"10.1016\/j.bcp.2022.115295_b0580","doi-asserted-by":"crossref","first-page":"24840","DOI":"10.1073\/pnas.1908113116","article-title":"Early epigenomic and transcriptional changes reveal Elk-1 transcription factor as a therapeutic target in Huntington's disease","volume":"116","author":"Yildirim","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"23","key":"10.1016\/j.bcp.2022.115295_b0585","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1242\/dev.025080","article-title":"Huttner, miRNAs are essential for survival and differentiation of newborn neurons but not for expansion of neural progenitors during early neurogenesis in the mouse embryonic neocortex","volume":"135","author":"De Pietri Tonelli","year":"2008","journal-title":"Development"},{"key":"10.1016\/j.bcp.2022.115295_b0590","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.705348","article-title":"MicroRNAs in Huntington's Disease: Diagnostic Biomarkers or Therapeutic Agents?","volume":"15","author":"Dong","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2019.101664","article-title":"microRNA dysregulation in neurodegenerative diseases: A systematic review","volume":"182","author":"Ju\u017awik","year":"2019","journal-title":"Prog. Neurobiol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b0600","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/2211536605666151204111323","article-title":"Heat Shock Factor 1-Regulated miRNAs Can Target Huntingtin and Suppress Aggregates of Mutant Huntingtin","volume":"4","author":"Das","year":"2015","journal-title":"Microrna"},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0605","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/15476286.2018.1553482","article-title":"Identification and epigenetic analysis of divergent long non-coding RNAs in multilineage differentiation of human Neural Progenitor Cells","volume":"16","author":"Prajapati","year":"2019","journal-title":"RNA Biol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b0610","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","article-title":"A microRNA-based gene dysregulation pathway in Huntington's disease","volume":"29","author":"Johnson","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bcp.2022.115295_b0615","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1756-6606-7-46","article-title":"microRNA-128a dysregulation in transgenic Huntington's disease monkeys","volume":"7","author":"Kocerha","year":"2014","journal-title":"Mol. Brain"},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b0620","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1093\/hmg\/ddr111","article-title":"Hsa-miR-34b is a plasma-stable microRNA that is elevated in pre-manifest Huntington's disease","volume":"20","author":"Gaughwin","year":"2011","journal-title":"Hum. Mol. Genet."},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0625","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0630","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1073\/pnas.0509567103","article-title":"Lewy bodies","volume":"103","author":"Shults","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"22","key":"10.1016\/j.bcp.2022.115295_b0635","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228421","article-title":"Neurodegeneration and Inflammation-An Interesting Interplay in Parkinson's Disease","volume":"21","author":"Marogianni","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2022.115295_b0640","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1440-1789.2007.00803.x","article-title":"The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates","volume":"27","author":"Wakabayashi","year":"2007","journal-title":"Neuropathology"},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b0645","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","article-title":"Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease","volume":"46","author":"Nalls","year":"2014","journal-title":"Nat. Genet."},{"issue":"10","key":"10.1016\/j.bcp.2022.115295_b0650","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.4161\/epi.25865","article-title":"Distinctive patterns of DNA methylation associated with Parkinson disease: identification of concordant epigenetic changes in brain and peripheral blood leukocytes","volume":"8","author":"Masliah","year":"2013","journal-title":"Epigenetics"},{"issue":"18","key":"10.1016\/j.bcp.2022.115295_b0655","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186918","article-title":"Epigenetic Mechanisms of Learning and Memory: Implications for Aging","volume":"21","author":"Creighton","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bcp.2022.115295_b0660","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1042\/BST20170574","article-title":"Mammalian DNA methyltransferases: new discoveries and open questions","volume":"46","author":"Gowher","year":"2018","journal-title":"Biochem. Soc. Trans."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2022.115295_b0665","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.pneurobio.2005.09.001","article-title":"The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease","volume":"77","author":"Jankovic","year":"2005","journal-title":"Prog. Neurobiol."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2022.115295_b0670","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2014.12.017","article-title":"Epigenetic mechanisms in Parkinson's disease","volume":"349","author":"Feng","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bcp.2022.115295_b0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2020.140591","article-title":"Parkinson's disease and pesticides: Are microRNAs the missing link?","volume":"744","author":"Aloizou","year":"2020","journal-title":"Sci. Total Environ."},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b0680","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.nbd.2008.09.010","article-title":"Different methylation of the TNF-alpha promoter in cortex and substantia nigra: Implications for selective neuronal vulnerability","volume":"32","author":"Pieper","year":"2008","journal-title":"Neurobiol. Dis."},{"issue":"20","key":"10.1016\/j.bcp.2022.115295_b0685","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"Kontopoulos","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0690","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/hmg\/ddu526","article-title":"PINK1 positively regulates HDAC3 to suppress dopaminergic neuronal cell death","volume":"24","author":"Choi","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0695","doi-asserted-by":"crossref","first-page":"17757","DOI":"10.1038\/s41598-020-74916-x","article-title":"Endoplasmic reticulum stress-related neuroinflammation and neural stem cells decrease in mice exposure to paraquat","volume":"10","author":"Yang","year":"2020","journal-title":"Sci. Rep."},{"issue":"7259","key":"10.1016\/j.bcp.2022.115295_b0700","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/nature08248","article-title":"L1 retrotransposition in human neural progenitor cells","volume":"460","author":"Coufal","year":"2009","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.bcp.2022.115295_b0705","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1369\/jhc.2008.951251","article-title":"Histone modifications and nuclear architecture: a review","volume":"56","author":"B\u00e1rtov\u00e1","year":"2008","journal-title":"J. Histochem. Cytochem."},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0710","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1242\/dev.089359","article-title":"Epigenetic mechanisms in the development and maintenance of dopaminergic neurons","volume":"140","author":"van Heesbeen","year":"2013","journal-title":"Development"},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b0715","doi-asserted-by":"crossref","first-page":"19307","DOI":"10.1002\/jcp.28622","article-title":"Gheibi Hayat, Involvement of aberrant regulation of epigenetic mechanisms in the pathogenesis of Parkinson's disease and epigenetic-based therapies","volume":"234","author":"Renani","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b0720","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.4103\/1673-5374.306065","article-title":"Considerations on the concept, definition, and diagnosis of amyotrophic lateral sclerosis","volume":"16","author":"Xu","year":"2021","journal-title":"Neural. Regen. Res."},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b0725","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.mayocp.2018.04.007","article-title":"Amyotrophic Lateral Sclerosis: An Update for 2018","volume":"93","author":"Oskarsson","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bcp.2022.115295_b0730","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic lateral sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"46","key":"10.1016\/j.bcp.2022.115295_b0735","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1523\/JNEUROSCI.1639-11.2011","article-title":"Epigenetic regulation of motor neuron cell death through DNA methylation","volume":"31","author":"Chestnut","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0740","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3389\/fncel.2013.00279","article-title":"Mitochondrial DNMT3A and DNA methylation in skeletal muscle and CNS of transgenic mouse models of ALS","volume":"7","author":"Wong","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"7205","key":"10.1016\/j.bcp.2022.115295_b0745","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nature07107","article-title":"Genome-scale DNA methylation maps of pluripotent and differentiated cells","volume":"454","author":"Meissner","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2022.115295_b0750","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2018.08.009","article-title":"Epigenetic Changes Associated with the Expression of Amyotrophic Lateral Sclerosis (ALS) Causing Genes","volume":"390","author":"Masala","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2022.115295_b0755","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-981-13-0529-0_6","article-title":"Amyotrophic Lateral Sclerosis Model","volume":"1076","author":"Azuma","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0760","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s00401-013-1199-1","article-title":"Reduced C9orf72 gene expression in c9FTD\/ALS is caused by histone trimethylation, an epigenetic event detectable in blood","volume":"126","author":"Belzil","year":"2013","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b0765","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/hmg\/ddn375","article-title":"Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degeneration","volume":"18","author":"Simpson","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2022.115295_b0770","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ebiom.2019.01.038","article-title":"Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis","volume":"40","author":"Pigna","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0775","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s12264-015-1539-3","article-title":"Histone deacetylase 6 delays motor neuron degeneration by ameliorating the autophagic flux defect in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"31","author":"Chen","year":"2015","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bcp.2022.115295_b0780","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mcn.2015.12.008","article-title":"Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms","volume":"71","author":"Figueroa-Romero","year":"2016","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0785","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1756-6606-6-26","article-title":"Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels","volume":"6","author":"Campos-Melo","year":"2013","journal-title":"Mol. Brain"},{"issue":"7","key":"10.1016\/j.bcp.2022.115295_b0790","doi-asserted-by":"crossref","first-page":"4986","DOI":"10.1007\/s12035-016-0042-9","article-title":"Differentiation Induces Dramatic Changes in miRNA Profile, Where Loss of Dicer Diverts Differentiating SH-SY5Y Cells Toward Senescence","volume":"54","author":"Jauhari","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0795","doi-asserted-by":"crossref","first-page":"e89065","DOI":"10.1371\/journal.pone.0089065","article-title":"MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis","volume":"9","author":"Toivonen","year":"2014","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b0800","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41593-021-00936-z","article-title":"Circulating miR-181 is a prognostic biomarker for amyotrophic lateral sclerosis","volume":"24","author":"Magen","year":"2021","journal-title":"Nat. Neurosci."},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b0805","doi-asserted-by":"crossref","first-page":"e1239","DOI":"10.1038\/tp.2017.202","article-title":"The BET\/BRD inhibitor JQ1 improves brain plasticity in WT and APP mice","volume":"7","author":"Benito","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b0810","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2174\/1567205013666160427101832","article-title":"The BET-Bromodomain Inhibitor JQ1 Reduces Inflammation and Tau Phosphorylation at Ser396 in the Brain of the 3xTg Model of Alzheimer's Disease","volume":"13","author":"Magistri","year":"2016","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.bcp.2022.115295_b0815","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.brainresbull.2021.12.004","article-title":"Simultaneous administration of bromodomain and histone deacetylase I inhibitors alleviates cognition deficit in Alzheimer's model of rats","volume":"179","author":"Badrikoohi","year":"2022","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0820","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddz264","article-title":"Treatment with JQ1, a BET bromodomain inhibitor, is selectively detrimental to R6\/2 Huntington's disease mice","volume":"29","author":"Kedaigle","year":"2020","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0825","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.3233\/JAD-210570","article-title":"Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial","volume":"83","author":"Cummings","year":"2021","journal-title":"J. Alzheimers Dis."},{"issue":"15","key":"10.1016\/j.bcp.2022.115295_b0830","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1093\/jnci\/92.15.1210","article-title":"Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells","volume":"92","author":"Marks","year":"2000","journal-title":"J. Natl Cancer Inst."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0835","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"18","key":"10.1016\/j.bcp.2022.115295_b0840","doi-asserted-by":"crossref","first-page":"16101","DOI":"10.1074\/jbc.M110.193433","article-title":"Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia","volume":"286","author":"Cenik","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0845","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/npp.2009.197","article-title":"Inhibitors of class 1 histone deacetylases reverse contextual memory deficits in a mouse model of Alzheimer's disease","volume":"35","author":"Kilgore","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"6857","key":"10.1016\/j.bcp.2022.115295_b0850","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.bcp.2022.115295_b0855","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1038\/npp.2011.128","article-title":"Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease","volume":"36","author":"Chiu","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.bcp.2022.115295_b0860","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models","volume":"205","author":"Qing","year":"2008","journal-title":"J. Exp. Med."},{"issue":"22","key":"10.1016\/j.bcp.2022.115295_b0865","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1021\/bi035627j","article-title":"Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing","volume":"43","author":"Su","year":"2004","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0870","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2009.08.001","article-title":"Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington's disease","volume":"94","author":"Z\u00e1dori","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0875","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1476-5381.2011.01575.x","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage","volume":"165","author":"Chen","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b0880","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12640-009-9090-5","article-title":"Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein","volume":"17","author":"Monti","year":"2010","journal-title":"Neurotox. Res."},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b0885","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1111\/j.1460-9568.2004.03765.x","article-title":"Benefit of valproic acid in suppressing disease progression of ALS model mice","volume":"20","author":"Sugai","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0890","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12035-014-8751-4","article-title":"Valproic acid alleviates memory deficits and attenuates amyloid-\u03b2 deposition in transgenic mouse model of Alzheimer's disease","volume":"51","author":"Xuan","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0895","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5114\/fn.2015.56545","article-title":"Protective effect of valproic acid on cultured motor neurons under glutamate excitotoxic conditions","volume":"53","author":"Naga\u0144ska","year":"2015","journal-title":"Ultrastructural study, Folia Neuropathol."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0900","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2011-110080","article-title":"Sodium butyrate improves memory function in an Alzheimer's disease mouse model when administered at an advanced stage of disease progression","volume":"26","author":"Govindarajan","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"28","key":"10.1016\/j.bcp.2022.115295_b0905","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bcp.2022.115295_b0910","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbr.2015.05.052","article-title":"Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: Modulation of histone deacetylase activity","volume":"291","author":"Sharma","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bcp.2022.115295_b0915","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2015.05.012","article-title":"Post-occlusion administration of sodium butyrate attenuates cognitive impairment in a rat model of chronic cerebral hypoperfusion","volume":"135","author":"Liu","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"43","key":"10.1016\/j.bcp.2022.115295_b0920","doi-asserted-by":"crossref","first-page":"11174","DOI":"10.1523\/JNEUROSCI.3004-06.2006","article-title":"Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells: effect of histone deacetylase inhibitors","volume":"26","author":"Oliveira","year":"2006","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b0925","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/hmg\/ddm078","article-title":"Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models","volume":"16","author":"Sadri-Vakili","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2022.115295_b0930","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","article-title":"Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson's disease","volume":"246","author":"St Laurent","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.bcp.2022.115295_b0935","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jns.2017.08.3235","article-title":"Sodium butyrate exerts protective effect against Parkinson's disease in mice via stimulation of glucagon like peptide-1","volume":"381","author":"Liu","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2022.115295_b0940","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddx114","article-title":"Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage","volume":"26","author":"Paiva","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bcp.2022.115295_b0945","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1038\/tp.2015.90","article-title":"Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene","volume":"5","author":"Lee","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b0950","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/cns.12217","article-title":"Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+","volume":"20","author":"Zhu","year":"2014","journal-title":"CNS Neurosci. Ther."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2022.115295_b0955","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.lfs.2014.01.064","article-title":"Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease","volume":"99","author":"Yang","year":"2014","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0960","doi-asserted-by":"crossref","DOI":"10.1007\/s12031-014-0461-x","article-title":"Histone deacetylase inhibitor, trichostatin A, improves learning and memory in high-fat diet-induced cognitive deficits in mice","volume":"56","author":"Sharma","year":"2015","journal-title":"J. Mol. Neurosci."},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b0965","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","article-title":"Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity","volume":"21","author":"Giralt","year":"2012","journal-title":"Hum. Mol. Genet."},{"issue":"26","key":"10.1016\/j.bcp.2022.115295_b0970","doi-asserted-by":"crossref","first-page":"15179","DOI":"10.1073\/pnas.261400698","article-title":"Histone deacetylase inhibitors reduce polyglutamine toxicity","volume":"98","author":"McCampbell","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.bcp.2022.115295_b0975","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1017\/S1461145708009024","article-title":"Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons","volume":"11","author":"Wu","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bcp.2022.115295_b0980","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuropharm.2015.07.015","article-title":"NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson's disease","volume":"99","author":"Suo","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b0985","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2011.06.003","article-title":"Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis","volume":"231","author":"Yoo","year":"2011","journal-title":"Exp. Neurol."},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b0990","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1021\/jm049002a","article-title":"Class II (IIa)-selective histone deacetylase inhibitors. 1. Synthesis and biological evaluation of novel (aryloxopropenyl)pyrrolyl hydroxyamides","volume":"48","author":"Mai","year":"2005","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b0995","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s12035-014-8820-8","article-title":"Class-IIa Histone Deacetylase Inhibition Promotes the Growth of Neural Processes and Protects Them Against Neurotoxic Insult","volume":"51","author":"Collins","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2022.115295_b1000","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2017.07.033","article-title":"Effect of Class II HDAC inhibition on glutamate transporter expression and survival in SOD1-ALS mice","volume":"656","author":"Lapucci","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2022.115295_b1005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbi.2022.02.025","article-title":"Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease","volume":"102","author":"Mazzocchi","year":"2022","journal-title":"Brain Behav. Immun."},{"issue":"31","key":"10.1016\/j.bcp.2022.115295_b1010","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b1015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/13543776.2019.1708901","article-title":"A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014\u20132019)","volume":"30","author":"Shen","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b1020","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3233\/JAD-140066","article-title":"Tubastatin A\/ACY-1215 improves cognition in Alzheimer's disease transgenic mice","volume":"41","author":"Zhang","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b1025","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s40478-019-0750-2","article-title":"Restoration of histone acetylation ameliorates disease and metabolic abnormalities in a FUS mouse model","volume":"7","author":"Rossaert","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b1030","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s41467-017-00911-y","article-title":"Van Den Bosch, HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients","volume":"8","author":"Guo","year":"2017","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.bcp.2022.115295_b1035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222011224","article-title":"Histone Deacetylase Inhibition Regulates Lipid Homeostasis in a Mouse Model of Amyotrophic Lateral Sclerosis","volume":"22","author":"Burg","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2022.115295_b1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113821","article-title":"Synthesis and biological evaluation of selective histone deacetylase 6 inhibitors as multifunctional agents against Alzheimer's disease","volume":"225","author":"Wang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2022.115295_b1045","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s12272-018-1045-z","article-title":"Aspirin-inspired acetyl-donating HDACs inhibitors","volume":"41","author":"Lim","year":"2018","journal-title":"Arch. Pharm. Res."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b1050","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3233\/JHD-160226","article-title":"LBH589 A Hydroxamic Acid-Derived HDAC Inhibitor, is Neuroprotective in Mouse Models of Huntington's Disease","volume":"5","author":"Chopra","year":"2016","journal-title":"J. Huntingtons. Dis."},{"issue":"7","key":"10.1016\/j.bcp.2022.115295_b1055","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1038\/npp.2008.229","article-title":"Phenylbutyrate ameliorates cognitive deficit and reduces tau pathology in an Alzheimer's disease mouse model","volume":"34","author":"Ricobaraza","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b1060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171\u201382Q transgenic mouse model of Huntington's disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b1065","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1385\/NMM:5:3:235","article-title":"Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity","volume":"5","author":"Gardian","year":"2004","journal-title":"Neuromolecular Med"},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b1070","doi-asserted-by":"crossref","first-page":"e38113","DOI":"10.1371\/journal.pone.0038113","article-title":"Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson's disease","volume":"7","author":"Roy","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.bcp.2022.115295_b1075","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1471-4159.2005.03077.x","article-title":"Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis mice","volume":"93","author":"Ryu","year":"2005","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b1080","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2005.09.013","article-title":"Additive neuroprotective effects of a histone deacetylase inhibitor and a catalytic antioxidant in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"22","author":"Petri","year":"2006","journal-title":"Neurobiol. Dis."},{"issue":"24","key":"10.1016\/j.bcp.2022.115295_b1085","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1007\/s00018-008-8357-y","article-title":"Biological and potential therapeutic roles of sirtuin deacetylases","volume":"65","author":"Taylor","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"7","key":"10.1016\/j.bcp.2022.115295_b1090","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCRESAHA.118.312498","article-title":"Sirtuins and NAD in the Development and Treatment of Metabolic and Cardiovascular Diseases","volume":"123","author":"Kane","year":"2018","journal-title":"Circ. Res."},{"issue":"18","key":"10.1016\/j.bcp.2022.115295_b1095","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1080\/15384101.2019.1634953","article-title":"The sirtuin family in cancer","volume":"18","author":"Costa-Machado","year":"2019","journal-title":"Cell Cycle"},{"issue":"24","key":"10.1016\/j.bcp.2022.115295_b1100","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1021\/acschemneuro.0c00696","article-title":"Sirtuins and Their Implications in Neurodegenerative Diseases from a Drug Discovery Perspective","volume":"11","author":"Yeong","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"12","key":"10.1016\/j.bcp.2022.115295_b1105","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1039\/C8FO00964C","article-title":"Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T \u03b1-synuclein mouse model of Parkinson's disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.bcp.2022.115295_b1110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuint.2017.05.013","article-title":"Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation","volume":"117","author":"Vidoni","year":"2018","journal-title":"Neurochem. Int."},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b1115","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1523\/JNEUROSCI.3046-16.2017","article-title":"An Agonist of the Protective Factor SIRT1 Improves Functional Recovery and Promotes Neuronal Survival by Attenuating Inflammation after Spinal Cord Injury","volume":"37","author":"Chen","year":"2017","journal-title":"J. Neurosci."},{"issue":"13","key":"10.1016\/j.bcp.2022.115295_b1120","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","article-title":"SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis","volume":"26","author":"Kim","year":"2007","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b1125","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3233\/JAD-140444","article-title":"Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease","volume":"42","author":"Porquet","year":"2014","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b1130","doi-asserted-by":"crossref","first-page":"12875","DOI":"10.1038\/s41598-018-30659-4","article-title":"Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model","volume":"8","author":"Schiaffino","year":"2018","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b1135","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/hmg\/ddu010","article-title":"A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington's disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"5837","key":"10.1016\/j.bcp.2022.115295_b1140","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease","volume":"317","author":"Outeiro","year":"2007","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b1145","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.celrep.2012.11.001","article-title":"The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington's disease mouse models","volume":"2","author":"Chopra","year":"2012","journal-title":"Cell Rep"},{"issue":"17","key":"10.1016\/j.bcp.2022.115295_b1150","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1073\/pnas.1002924107","article-title":"SIRT2 inhibition achieves neuroprotection by decreasing sterol biosynthesis","volume":"107","author":"Luthi-Carter","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bcp.2022.115295_b1155","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphar.2012.00042","article-title":"Inhibition of Sirtuin 2 with Sulfobenzoic Acid Derivative AK1 is Non-Toxic and Potentially Neuroprotective in a Mouse Model of Frontotemporal Dementia","volume":"3","author":"Spires-Jones","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b1160","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3233\/JAD-151135","article-title":"Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-\u03b2 Protein Precursor Processing in Two Alzheimer's Disease Mouse Models","volume":"53","author":"Biella","year":"2016","journal-title":"J. Alzheimers Dis."},{"issue":"6","key":"10.1016\/j.bcp.2022.115295_b1165","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/biof.1385","article-title":"Neuroprotective effects of honokiol: from chemistry to medicine","volume":"43","author":"Talarek","year":"2017","journal-title":"BioFactors"},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b1170","doi-asserted-by":"crossref","first-page":"e0190350","DOI":"10.1371\/journal.pone.0190350","article-title":"SIRT3 activator Honokiol attenuates \u03b2-Amyloid by modulating amyloidogenic pathway","volume":"13","author":"Ramesh","year":"2018","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b1175","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/cns.13053","article-title":"SIRT3 activator honokiol ameliorates surgery\/anesthesia-induced cognitive decline in mice through anti-oxidative stress and anti-inflammatory in hippocampus","volume":"25","author":"Ye","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bcp.2022.115295_b1180","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.neubiorev.2021.10.047","article-title":"Multifaced role of protein deacetylase sirtuins in neurodegenerative disease","volume":"132","author":"Gupta","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b1185","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s13311-020-00853-2","article-title":"Immunotherapies for Aging-Related Neurodegenerative Diseases-Emerging Perspectives and New Targets","volume":"17","author":"Kwon","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"10\u201312","key":"10.1016\/j.bcp.2022.115295_b1190","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbagrm.2010.08.012","article-title":"Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases","volume":"1799","author":"Selvi","year":"2010","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids"},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b1195","doi-asserted-by":"crossref","first-page":"e85570","DOI":"10.1371\/journal.pone.0085570","article-title":"The anti-tumor histone deacetylase inhibitor SAHA and the natural flavonoid curcumin exhibit synergistic neuroprotection against amyloid-beta toxicity","volume":"9","author":"Meng","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b1200","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12640-012-9315-x","article-title":"Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic-acid-induced Huntington's disease-like symptoms in rats","volume":"22","author":"Kalonia","year":"2012","journal-title":"Neurotox. Res."},{"issue":"9","key":"10.1016\/j.bcp.2022.115295_b1205","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/ncpneuro0586","article-title":"Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders","volume":"3","author":"Heneka","year":"2007","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"10.1016\/j.bcp.2022.115295_b1210","doi-asserted-by":"crossref","DOI":"10.1155\/2008\/864140","article-title":"Regulation of Glial Cell Functions by PPAR-gamma Natural and Synthetic Agonists","volume":"2008","author":"Bernardo","year":"2008","journal-title":"PPAR Res."},{"issue":"2","key":"10.1016\/j.bcp.2022.115295_b1215","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12640-014-9458-z","article-title":"Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPAR\u03b3 and HDAC pathways","volume":"26","author":"Mishra","year":"2014","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.bcp.2022.115295_b1220","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12192-019-01064-1","article-title":"Depending on the stress, histone deacetylase inhibitors act as heat shock protein co-inducers in motor neurons and potentiate arimoclomol, exerting neuroprotection through multiple mechanisms in ALS models","volume":"25","author":"Kuta","year":"2020","journal-title":"Cell Stress Chaperones"},{"issue":"3","key":"10.1016\/j.bcp.2022.115295_b1225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23031047","article-title":"Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK\/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice","volume":"23","author":"Bankole","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.bcp.2022.115295_b1230","doi-asserted-by":"crossref","first-page":"e1705694","DOI":"10.1002\/adma.201705694","article-title":"Nanomaterials in Neural-Stem-Cell-Mediated Regenerative Medicine: Imaging and Treatment of Neurological Diseases","volume":"30","author":"Zhang","year":"2018","journal-title":"Adv. Mater."},{"issue":"6158","key":"10.1016\/j.bcp.2022.115295_b1235","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1126\/science.1242576","article-title":"Resident neural stem cells restrict tissue damage and neuronal loss after spinal cord injury in mice","volume":"342","author":"Sabelstr\u00f6m","year":"2013","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.bcp.2022.115295_b1240","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1039\/C6CC09085K","article-title":"Self-assembled lipoprotein based gold nanoparticles for detection and photothermal disaggregation of \u03b2-amyloid aggregates","volume":"53","author":"Martins","year":"2017","journal-title":"Chem. Commun. (Camb.)"},{"issue":"4","key":"10.1016\/j.bcp.2022.115295_b1245","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.nano.2018.03.004","article-title":"Promoting neuroregeneration by applying dynamic magnetic fields to a novel nanomedicine: Superparamagnetic iron oxide (SPIO)-gold nanoparticles bounded with nerve growth factor (NGF)","volume":"14","author":"Yuan","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bcp.2022.115295_b1250","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biomaterials.2017.07.023","article-title":"Erythrocyte membrane-encapsulated celecoxib improves the cognitive decline of Alzheimer's disease by concurrently inducing neurogenesis and reducing apoptosis in APP\/PS1 transgenic mice","volume":"145","author":"Guo","year":"2017","journal-title":"Biomaterials"},{"issue":"7696","key":"10.1016\/j.bcp.2022.115295_b1255","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature25975","article-title":"Human hippocampal neurogenesis drops sharply in children to undetectable levels in adults","volume":"555","author":"Sorrells","year":"2018","journal-title":"Nature"},{"issue":"Suppl","key":"10.1016\/j.bcp.2022.115295_b1260","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/nm1064","article-title":"Stem cell therapy for human neurodegenerative disorders-how to make it work","volume":"10","author":"Lindvall","year":"2004","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.bcp.2022.115295_b1265","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/hipo.22405","article-title":"Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss","volume":"25","author":"Ager","year":"2015","journal-title":"Hippocampus"},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b1270","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.7150\/thno.55680","article-title":"A novel small-molecule PROTAC selectively promotes tau clearance to improve cognitive functions in Alzheimer-like models","volume":"11","author":"Wang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2022.115295_b1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101616","article-title":"Targeted protein degraders march towards the clinic for neurodegenerative diseases","volume":"78","author":"Kumar","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.bcp.2022.115295_b1280","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2022.105308","article-title":"Autophagy system as a potential therapeutic target for neurodegenerative diseases","volume":"155","author":"Cui","year":"2022","journal-title":"Neurochem. Int."},{"issue":"11","key":"10.1016\/j.bcp.2022.115295_b1285","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/hmg\/ddq093","article-title":"Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease","volume":"19","author":"Rose","year":"2010","journal-title":"Hum. Mol. Genet."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222003896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295222003896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:39:26Z","timestamp":1757770766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295222003896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":257,"alternative-id":["S0006295222003896"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115295","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2022.115295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115295"}}